Thin medical professional liability pricing has survived for the better part of a decade on a single recurring offset: money released from prior-year reserves. That offset is running out. The line's combined ratio hit 112% after policyholder dividends in the first quarter of 2026, on the highest first-quarter premium volume in 20 years, while calendar-year 2025 favorable reserve development narrowed to $155 million and claims-made carriers separately booked $259 million of adverse development (Milliman, July 27, 2026; AM Best, May 6, 2026).

The Release Engine Runs in Reverse

MPL's 2025 underwriting loss widened to $712 million from $546 million in 2024, even as direct written premium climbed 3.6% to $9.4 billion, the highest annual total AM Best has recorded for the segment (AM Best, May 6, 2026). Favorable reserve development, which has offset underpriced accident years since the last hard market cycle turned in the mid-2010s, shrank to $155 million industry-wide in 2025. Layered underneath that net figure, claims-made carriers alone recognized $259 million of adverse development, partially offset by $15.7 million of favorable development on occurrence business (Risk & Insurance, April 20, 2026). AM Best senior director Vicky Riggs framed the pricing environment behind the shortfall directly: "The premium growth in 2025 was generally below expectations, reflecting competitive forces impacting carriers pushing for higher rate increases amid rising claims severity" (AM Best, May 6, 2026).

That reversal matters most on the claims-made book, where the reporting lag between policy issuance and ultimate loss recognition means a mis-picked accident-year loss ratio compounds for several report years before it surfaces in a reserve study. A pricing actuary who set the 2026 accident-year loss pick assuming a continuation of the release pattern that held through 2024 is now carrying an indication built on an offset the calendar-year data says has largely closed. Milliman's own first-quarter figures make the same point at shorter interval: the segment posted $18 million of adverse development in Q1 2026, against an average of roughly $11 million of favorable first-quarter development annually between 2020 and 2025 (Milliman, July 27, 2026). AM Best actuary Connor Brach put the near-term trajectory in writing: "We expect the property/casualty industry to report small reserve deficiencies for the MPL line in the near term, as social inflation takes its toll on claim frequency, severity, and both reporting and settlement patterns" (AM Best, May 6, 2026).

Record Premium, Rising Loss Adjustment Costs

Direct written premium reached $2.92 billion in the first quarter of 2026, roughly 2% above the same period a year earlier and about 40% higher on a cumulative basis than Q1 2017, with Milliman projecting the full-year total will exceed $8.8 billion, again the highest annual figure in 20 years (Milliman, July 27, 2026). Premium volume at a two-decade high is not evidence that rate is finally catching severity; combined with a 112% combined ratio, it is evidence that carriers are writing more business at a price that still is not adequate. Milliman's update also flags a rising loss adjustment expense ratio in the first quarter, which the firm attributes to the cost of investigating, managing, and resolving claims increasing, a signal that is easy to miss in a loss-ratio-only trend selection because it sits in LAE, not in indemnity severity.

That distinction is the second-order point pricing actuaries should not skip past. A rising LAE ratio alongside stable or rising indemnity severity indicates social inflation is reaching claim handling and settlement patterns, not only the size of the verdicts and settlements that eventually close a claim. Defense costs, expert witness fees, and extended litigation timelines all load into LAE, and a trend selection built purely on indemnity loss development will systematically understate the true cost trajectory of a book where more claims are proceeding to trial rather than settling early.

Investment Income Is the Only Reason the Segment Is Profitable

MPL specialty writers still posted a second consecutive year of pretax earnings above $1 billion in 2025, but net income fell 22% to $1.6 billion, and the entire positive result traces to net investment income rather than underwriting (AM Best, May 6, 2026). That is the classic soft-rate-on-the-float pattern: an underwriting loss widening for a second straight year, masked at the bottom line by yield on a portfolio that has benefited from several years of higher rates. The mask is not permanent. If reinvestment yields plateau as the current higher-rate bond vintage rolls off, the segment loses the offset keeping reported earnings positive while the accident-year loss ratio deteriorates. The investment-income cushion belongs on the balance sheet, not in the 2027 accident-year loss pick.

Severity, Not Frequency, Is Driving the Trend

The rate environment behind these results has been building for seven straight years. The AMA's April 2026 Policy Research Perspective, drawing on the Medical Liability Monitor's annual rate survey, found that the share of reported premiums rising year over year jumped from 13.7% in 2018 to 39.9% in 2025, with 57.0% unchanged and only 3.1% declining between 2024 and 2025. Thirty-six states recorded at least one premium increase in 2025, and the increases are not evenly spread: Pennsylvania and New York each had more than 90% of their reported premiums rise, several for a repeated double-digit year (AMA Policy Research Perspective, April 2026). The AMA's own historical comparison bounds how far this cycle has run: 2003 and 2004, the last true hard market for the line, saw 77.4% and 82.1% of reported premiums rise. Seven years at a 39.9% peak share is real hardening, not yet that severity.

The underlying driver is claim severity, not claim count. National Practitioner Data Bank payment data shows the average malpractice payment reached approximately $514,000 in 2025, roughly 20% higher than in 2022 (Risk & Insurance, April 20, 2026, citing NAIC and NPDB data). A study commissioned by The Doctors Company estimated that economic and social inflation added $4 billion to physician-focused insurers' losses and expenses over the decade ending in 2024, or roughly 11% of booked losses for the period, with 2022 through 2024 alone running about $1.8 billion above what pre-2020 inflation assumptions would have projected (Carrier Management, September 2025, reporting on Moore Actuarial Consulting's analysis for The Doctors Company). Charged manual rates in the Medical Liability Monitor survey lag the severity trend generating this loss experience; they reflect what carriers filed and got approved, not the indicated trend those carriers are actually running against, and the public record does not disclose the size of that gap.

Venue Concentration Hits Monoline Writers Hardest

MPL's severity trend is not uniform across states, and that unevenness is where the pricing problem concentrates for the writers least able to diversify around it. Calendar-year 2025 loss ratios reported by S&P Global Ratings and cited by Risk & Insurance ran to 128.8% in New Mexico, 143.8% in Utah, and 125.7% in South Carolina, against a national aggregate of 75.9% (Risk & Insurance, April 20, 2026). Utah's loss ratio ran nearly 1.9 times the national aggregate; New Mexico's ran about 1.7 times.

JurisdictionCY2025 MPL Loss RatioMultiple of National Aggregate
Utah143.8%1.9x
New Mexico128.8%1.7x
South Carolina125.7%1.7x
U.S. aggregate75.9%1.0x

Source: S&P Global Ratings state-level data, reported by Risk & Insurance, April 20, 2026.

Much of the U.S. MPL market is written by single-state physician-owned mutuals and reciprocals with limited geographic spread, so a severity trend concentrated in a handful of plaintiff-friendly venues hits their entire book at once rather than blending into a diversified national result. The 2025 reserve charges disclosed across the segment show exactly that split. Curi Holdings, a physician-owned mutual, strengthened reserves by $129.2 million, and Physicians' Reciprocal Insurers strengthened by $59.3 million, both concentrated, monoline exposures where a single jurisdiction's verdict environment moves the entire result. Liberty Mutual and Farmers Insurance Group also strengthened MPL reserves, by $128 million and $94.5 million respectively, but both sit inside diversified multi-line balance sheets that absorb the charge alongside other segments (Risk & Insurance, April 20, 2026). A monoline physician mutual carrying a $129 million charge against a fraction of Liberty Mutual's premium base faces a materially different surplus-adequacy question than a diversified carrier absorbing a similar dollar charge.

What the Actuarial Opinions Already Say

The industry's own reserving actuaries have started putting this risk in writing. Statements of Actuarial Opinion filed with state regulators for year-end 2025, covering companies representing 90% of MPL premium, show that more than 60% now cite social inflation as a risk factor that could produce material adverse deviation from the carried reserve (Risk & Insurance, April 20, 2026). That disclosure rate is itself a data point pricing actuaries can use: when the majority of the market's own signing actuaries flag the same risk factor, treating social inflation as a qualitative caveat in a rate filing rather than a quantified loading understates what the reserving side of the same companies is already telling regulators.

The Desk

The 2027 accident-year loss ratio pick is the number that moves first. It can no longer assume the calendar-year favorable development that offset thin pricing through 2024; the claims-made book specifically needs a trend selection that reflects the $259 million of adverse development already booked against it, decomposed by indemnity and LAE rather than blended into a single medical severity factor. For carriers writing concentrated books in Utah, New Mexico, or South Carolina, the excess reinsurance retention set at the last renewal should be revisited against the 2025 loss ratio data before the next treaty renews; a retention calibrated to a national 75.9% aggregate loss ratio is not calibrated to a book running 1.7 to 1.9 times that figure. And for physician-owned mutuals and reciprocals carrying reserve charges on the order of Curi Holdings' or Physicians' Reciprocal's 2025 disclosures, the surplus-adequacy question belongs on the same agenda as the rate filing, not a separate one. Milliman's next quarterly update lands in late October 2026; the next Medical Liability Monitor rate survey publishes in the first half of 2027 and will show whether the 39.9% share of premiums rising extends its seventh straight year of increases into an eighth.

Further Reading

Sources